Research Research Research Programs Systems, Pathways & Targets Biotechnology, Imaging & Drug Development Cancer Control Clinical Research Disease-Oriented Teams Stern Center for Cancer Clinical Trials and Research Protocol Review and Monitoring Committee Research Resources Shared Resources Funding Opportunities Membership Guidelines Acknowledgement of Grant and Shared Resources Centers & Institutes Anti-Cancer Challenge Research Anti-Cancer Challenge RFP Team Funds Anti-Cancer Challenge Past Awardees Clinical Research At the UCI Chao Family Comprehensive Cancer Center (CFCCC) — Orange County's only National Cancer Institute-designated comprehensive cancer center — patients receive compassionate and highly personalized treatment. The cancer center also provides patients with access to clinical trials and cutting-edge treatments as they are developed. At any given time, UCI is participating in at least 200 clinical trials, many of them developed by CFCCC members. For more information, please contact us at ucstudy@hs.uci.edu or 877-827-8839. Home Research Clinical Research The Stern Center for Cancer Clinical Trials and Research The Sue and Ralph Stern Center for Cancer Clinical Trials and Research supports the mission of the CFCCC to DISCOVER, TEACH and HEAL with the fundamental goal to substantially impact cancer research and improve outcomes in the Orange County catchment area and beyond. The Stern Center nurtures a culture of outstanding clinical research with clinical trials being the most important treatment option for all our patients. Learn More Clinical Trials Flowcharts The flowcharts are designed to help you identify CFCCC clinical trials that are associated with specific types of cancer. If there is a clinical trial that you are interested in learning more about, please contact the Stern Center at ucstudy@hs.uci.edu or 877-827-8839. View Flowcharts Disease-Oriented Teams Disease-Oriented Teams are multidisciplinary groups of basic, translational, clinical, and population health investigators who collaborate on a specific cancer area in order to further the translation of CFCCC discoveries through the pipeline towards interventional clinical trials. As the first component of the CFCCC’s two-step clinical research review process, the focus of the DOTs is to ensure rigorous internal scientific review of protocols, curate the clinical trial portfolio, and drive innovation. Learn More Protocol Review and Monitoring Committee The CFCCC’s Protocol Review and Monitoring Committee (PRMC) is the second step in the review process for new cancer-related clinical research studies. The PRMC evaluates new studies for scientific merit, feasibility, overall portfolio balance, and potential to accrue populations that are underrepresented in clinical trials. The PRMC also monitors the progress and continued relevance of studies that are open to enrollment. Learn More Find A Trial Search from a comprehensive list of active trials that are currently open to recruitment conducted by investigators at CFCCC. Click Here Featured Cancer Clinical Trials These featured cancer clinical trials are currently open at the UCI Chao Family Comprehensive Center. Click Here Cancer Center Newsletters CFCCC's triannual newsletter, Innovations in Research, highlights the research and clinical trials of our members. Fall 2020 Newsletter Highlighting CFCCC's basic, clinical and translational research. Click Here Spring 2020 Newsletter Highlighting CFCCC's basic, clinical and translational research. Click Here Spring 2019 Newsletter Highlighting lung cancer research and clinical trials. Click Here Fall 2018 Newsletter Highlighting gynecologic cancer research and clinical trials. Click Here Spring 2018 Newsletter Highlighting GI cancer research and clinical trials. Click Here Fall 2017 Newsletter Highlighting breast cancer research and clinical trials. Click Here Winter 2017 Newsletter Highlighting hematology oncology research and clinical trials. Click Here